Clinical Trial Update: Liraglutide Treatment to Patients With Severe Renal Insufficiency [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating liraglutide in patients with type 2 diabetes mellitus and end-stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Bo Feldt-Rasmussen | Conditions: Type 2 Diabetes Mellitus, End-stage Renal Disease | Phase 4 | Status: COMPLETED